PELUCCHI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 6.938
EU - Europa 3.180
AS - Asia 3.090
SA - Sud America 570
AF - Africa 53
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.836
Nazione #
US - Stati Uniti d'America 6.785
SG - Singapore 1.223
CN - Cina 863
DE - Germania 558
RU - Federazione Russa 493
IT - Italia 487
BR - Brasile 470
SE - Svezia 407
HK - Hong Kong 392
IE - Irlanda 327
VN - Vietnam 240
UA - Ucraina 226
GB - Regno Unito 207
CA - Canada 122
FI - Finlandia 103
FR - Francia 100
IN - India 78
AT - Austria 65
KR - Corea 50
NL - Olanda 47
TR - Turchia 45
ID - Indonesia 36
AR - Argentina 35
BE - Belgio 33
DK - Danimarca 31
BD - Bangladesh 28
JP - Giappone 28
ZA - Sudafrica 27
MX - Messico 22
IQ - Iraq 21
EC - Ecuador 20
ES - Italia 20
PL - Polonia 20
PK - Pakistan 16
LT - Lituania 15
VE - Venezuela 14
CO - Colombia 13
SA - Arabia Saudita 10
IR - Iran 9
PY - Paraguay 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
RO - Romania 6
MA - Marocco 5
NP - Nepal 5
PE - Perù 5
BG - Bulgaria 4
EG - Egitto 4
KG - Kirghizistan 4
MY - Malesia 4
PT - Portogallo 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
RS - Serbia 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SC - Seychelles 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 13.835
Città #
Ann Arbor 1.285
Singapore 740
Ashburn 660
Woodbridge 556
Fairfield 446
Chandler 388
Houston 388
Hong Kong 387
Frankfurt am Main 343
Dublin 315
Wilmington 256
Jacksonville 236
Dearborn 186
New York 176
Seattle 174
Milan 156
Cambridge 152
Beijing 143
Santa Clara 132
Los Angeles 111
Princeton 109
Nanjing 95
Hefei 84
Dallas 79
Ho Chi Minh City 75
Shanghai 68
The Dalles 68
Buffalo 58
Vienna 57
Lawrence 51
São Paulo 51
Munich 47
Altamura 45
Seoul 44
Moscow 43
Lachine 40
Hanoi 36
San Diego 35
Chicago 34
Brussels 29
Nanchang 28
Turku 27
Dong Ket 26
Helsinki 26
Jakarta 26
Ottawa 24
Rio de Janeiro 24
Shenyang 24
Boardman 23
Guangzhou 21
Tianjin 21
Turin 21
Council Bluffs 18
Hebei 18
Johannesburg 18
Orem 18
Tokyo 18
Andover 17
Jinan 17
Poplar 17
Jiaxing 16
London 16
Toronto 16
Montreal 15
Rome 15
Zhengzhou 15
Changsha 14
Chennai 14
Warsaw 14
Brooklyn 13
Denver 13
Boston 12
Indianapolis 12
Phoenix 12
San Jose 12
Stockholm 12
Campinas 11
Huizen 11
Brasília 10
Nuremberg 10
Pune 10
Quito 10
Columbus 9
Fremont 9
Mexico City 9
San Francisco 9
Atlanta 8
Belo Horizonte 8
Curitiba 8
Desio 8
Düsseldorf 8
Hangzhou 8
Kent 8
Kocaeli 8
Ningbo 8
Philadelphia 8
Tampa 8
Ankara 7
Auburn Hills 7
Biên Hòa 7
Totale 9.238
Nome #
Hepcidin regulation in a mouse model of acute hypoxia 521
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 382
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 362
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 334
Hif1a: A putative modifier of hemochromatosis 322
Inherited iron overload disorders 298
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 290
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 284
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 279
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 278
Idiopathic erythrocytosis: a germline disease? 276
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 276
Hepcidin regulation in a mouse model of acute hypoxia 274
Circulating factors are involved in hypoxia-induced hepcidin suppression 272
Type 3 hemochromatosis and beta-thalassemia trait 269
Unexplained isolated hyperferritinemia without iron overload 263
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 260
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 250
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 249
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 238
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 237
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 235
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 234
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 232
Ferroportin disease: A novel SLC40A1 mutation 231
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 226
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 226
Ceruloplasmin variants might have different effects in different iron overload disorders 226
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: the causes might be more heterogeneous than in thalassaemia. 223
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 218
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 218
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 213
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 213
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 211
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 211
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 207
Homozygous deletion of HFE: The Sardinian hemochromatosis? 206
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 205
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 204
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 201
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 200
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 196
Total iron-overload measurement in the human liver region by the magnetic iron detector. 191
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 190
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 187
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 181
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 180
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 180
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 176
Homozygosity for transferrin receptor-2 y250x mutation induces early iron overload 173
Erythrocytapheresis plus erythropoietin: An alternative therapy for selected patients with hemochromatosis and severe organ damage 167
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis 162
Angiotensin type 2 and mas receptor activation prevents myocardial fibrosis and hypertrophy through the reduction of inflammatory cell infiltration and local sympathetic activity in angiotensin ii‐dependent hypertension 161
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 152
Hypoxia-dependent hepcidin down-regulation: an in vitro study 151
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation 149
Interaction Between the PNPLA3 I148M Mutation, Body Weight, And Steatosis, In Determining The Progression To Cirrhosis In Hereditary Hemochromatosis 149
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 146
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 132
Interaction between the PNPLA3 I148M mutation and body weight in determining steatosis and the progression to cirrhosis in hereditary hemochromatosis 126
Hereditary Hyperferritinemia 125
Gene symbol: FTL. Disease: Hyperferritinemia-cataract syndrome 125
Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia 100
Molecular testing in hemochromatosis 80
Emerging nanocarrier systems for the enhanced delivery of active pharmaceutical ingredients to the intestine 21
Totale 14.154
Categoria #
all - tutte 46.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021677 0 0 0 0 0 84 86 71 98 136 84 118
2021/2022960 61 93 106 76 70 56 62 51 40 74 81 190
2022/20231.529 205 429 155 156 101 222 10 84 95 10 30 32
2023/2024982 40 48 43 45 107 272 194 50 42 15 18 108
2024/20252.288 122 193 114 91 238 104 132 110 261 374 220 329
2025/20263.449 721 334 473 749 880 292 0 0 0 0 0 0
Totale 14.154